FCGR2B and neoplasm: FcγRIIb-mediated internalization of anti-CD20 reduces phagocytosis of tumor B cells (68) and, thus, high FcγRIIb expression can be associated with shorter survival in patients with B-cells malignances after rituximab-containing regimens (70).